{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:23:05Z","timestamp":1787638985821,"version":"build-2736575974"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As CRC survival improves, the shifting contributions of metastatic and non-cancer causes to mortality remain poorly characterized, with implications for survivorship care and public health policy. This study aimed to examine temporal trends in CRC mortality with selected contributing conditions from 1999 to 2023 and project rates through 2040 across demographic and geographic subgroups in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This population-based cohort study utilized mortality data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database. The study included 1,323,609 US residents aged 25 years or older who died from 1999 through 2023 with colorectal cancer listed as the underlying cause of death. We analyzed selected contributing conditions recorded in the multiple cause-of-death field, including heart failure, ischemic heart disease, liver metastasis, lung metastasis, pulmonary embolism, and sepsis. Age-adjusted mortality rates (AAMRs) were calculated per 100,000 persons. Temporal trends were analyzed using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC). Future mortality rates were projected to 2040 using autoregressive integrated moving average (ARIMA) modeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall CRC AAMR declined from 32.06 in 1999 to 19.57 in 2023 (AAPC,\u22122.08%). Recent significant increases were observed in liver metastasis mortality from 2016 to 2023 (APC: 2.89%), lung metastasis mortality from 2017 to 2023 (APC: 2.08%), pulmonary embolism mortality from 2012 to 2023 (APC: 3.59%), and heart failure mortality from 2013 to 2023 (APC: 3.16%). These trends were most pronounced among adults aged 35\u201364 years, non-Hispanic Black individuals, and residents of the Southern US. Model-based projections indicate that overall lung metastasis mortality will continue to increase through 2040, whereas liver metastasis mortality will peak in 2028 and subsequently decline. In pre-pandemic sensitivity analyses, the post-2012 increase in PE mortality persisted, whereas recent increases in IHD, HF, liver metastasis, and sepsis mortality were attenuated or no longer statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite declining overall CRC mortality, recent increases were observed in several metastatic and noncancer contributing conditions. However, pre-pandemic sensitivity analyses suggested that some late-period changes may have been amplified during the COVID-19 era, whereas the increase in PE mortality clearly preceded the pandemic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1850707","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:36:32Z","timestamp":1787636192000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends and projections in cause-specific mortality among patients with colorectal cancer in the United States, 1999\u20132040"],"prefix":"10.3389","volume":"14","author":[{"given":"Ziyan","family":"He","sequence":"first","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Chen","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Hu","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Lin","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiqiu","family":"Deng","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cong","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Liu","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome","place":["Guangzhou, China"]},{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome","place":["Guangzhou, China"]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jamaoncol.2021.1364","article-title":"Association of screening lower endoscopy with colorectal cancer incidence and mortality in adults older than 75 years","volume":"7","author":"Ma","year":"2021","journal-title":"JAMA Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1056\/NEJM199305133281901","article-title":"Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study","volume":"328","author":"Mandel","year":"1993","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJMoa1300720","article-title":"Long-term mortality after screening for colorectal cancer","volume":"369","author":"Shaukat","year":"2013","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41575-022-00612-y","article-title":"Current and future colorectal cancer screening strategies","volume":"19","author":"Shaukat","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7326\/AITC202404160","article-title":"Screening for colorectal cancer","author":"Patel","year":"2024","journal-title":"Ann Intern Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa1100370","article-title":"Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths","volume":"366","author":"Zauber","year":"2012","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7326\/M17-0723","article-title":"Colonoscopy and colorectal cancer mortality in the veterans affairs health care system: a case-control study","volume":"168","author":"Kahi","year":"2018","journal-title":"Ann Intern Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","article-title":"Metastatic colorectal cancer: mechanisms and emerging therapeutics","volume":"44","author":"Shin","year":"2023","journal-title":"Trends Pharmacol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10552-005-0530-0","article-title":"Non-cancer mortality among people diagnosed with cancer (Australia)","volume":"17","author":"Baade","year":"2006","journal-title":"Cancer Causes Control."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.ejca.2014.04.009","article-title":"Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?","volume":"50","author":"van Erning","year":"2014","journal-title":"Eur J Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jamaoncol.2019.0695","article-title":"Body composition and cardiovascular events in patients with colorectal cancer: a population-based retrospective cohort study","volume":"5","author":"Brown","year":"2019","journal-title":"JAMA Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.2017.74.9739","article-title":"New-onset cardiovascular morbidity in older adults with stage I to III colorectal cancer","volume":"36","author":"Kenzik","year":"2018","journal-title":"J Clin Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.2005.04.2150","article-title":"Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival","volume":"24","author":"Alcalay","year":"2006","journal-title":"J Clin Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"S\u00f8rensen","year":"2000","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/SLA.0b013e3181d3d27c","article-title":"Readmission after colectomy for cancer predicts one-year mortality","volume":"251","author":"Greenblatt","year":"2010","journal-title":"Ann Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.ejso.2017.03.003","article-title":"In-hospital mortality, 30-day readmission, and length of hospital stay after surgery for primary colorectal cancer: a national population-based study","volume":"43","author":"Pucciarelli","year":"2017","journal-title":"Eur J Surg Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.ejca.2006.04.012","article-title":"Towards a pan-European consensus on the treatment of patients with colorectal liver metastases","volume":"42","author":"Van Cutsem","year":"2006","journal-title":"Eur J Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-022-00922-2","article-title":"Colorectal liver metastasis: molecular mechanism and interventional therapy","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct Target Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamasurg.2022.0300","article-title":"Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases","volume":"157","author":"Hernandez-Alejandro","year":"2022","journal-title":"JAMA Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13046-023-02729-7","article-title":"Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches","volume":"42","author":"Wang","year":"2023","journal-title":"J Exp Clin Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1136\/gut.2010.211557","article-title":"Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study","volume":"59","author":"Mitry","year":"2010","journal-title":"Gut."},{"key":"B25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ejca.2013.10.009","article-title":"Danish Colorectal Cancer Group. Occurrence and survival of synchronous pulmonary metastases in colorectal cancer: a nationwide cohort study","volume":"50","author":"Nordholm-Carstensen","year":"2014","journal-title":"Eur J Cancer."},{"key":"B26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/annonc\/mdw604","article-title":"Causes of death among cancer patients","volume":"28","author":"Zaorsky","year":"2017","journal-title":"Ann Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41568-024-00708-4","article-title":"Why do patients with cancer die?","volume":"24","author":"Boire","year":"2024","journal-title":"Nat Rev Cancer."},{"key":"B28","doi-asserted-by":"publisher","first-page":"647179","DOI":"10.3389\/fonc.2021.647179","article-title":"Causes of death after colorectal cancer diagnosis: a population-based study","volume":"11","author":"Feng","year":"2021","journal-title":"Front Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12931-025-03319-1","article-title":"Trends in pulmonary embolism mortality in cancer patients in the United States from 1999-2022- A CDC Wonder database study","volume":"26","author":"Dort","year":"2025","journal-title":"Respir Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e2460315","DOI":"10.1001\/jamanetworkopen.2024.60315","article-title":"Pulmonary embolism-related mortality in patients with cancer","volume":"8","author":"Zuin","year":"2025","journal-title":"JAMA Netw Open."},{"key":"B31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA."},{"key":"B32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol."},{"key":"B33","unstructured":"National Center for Health Statistics mortality data on CDC Wonder\n          \n          2025"},{"key":"B34","unstructured":"National Vital Statistics System: Mortality Data. Centers for Disease Control and Prevention\n          \n          2026"},{"key":"B35","unstructured":"Mortality Multiple Cause-of-Death Public Use Data File Documentation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med."},{"key":"B37","volume-title":"International Statistical Classification of Diseases, Tenth Revision (ICD-10)","year":"1992"},{"key":"B38","unstructured":"ICD-10, International Statistical Classification of Diseases and Related Health Problems: Tabular List\n          \n          2024"},{"key":"B39","unstructured":"Instructions for Classification of Underlying and Multiple Causes of Death-2024\n          \n          2024"},{"key":"B40","unstructured":"Instructions for Classifying Multiple Causes of Death"},{"key":"B41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijantimicag.2019.03.004","article-title":"Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states","volume":"54","author":"Goldstein","year":"2019","journal-title":"Int J Antimicrob Agents."},{"key":"B42","first-page":"1","article-title":"Age standardization of death rates: implementation of the year 2000 standard","volume":"47","author":"Anderson","year":"1998","journal-title":"Natl Vital Stat Rep."},{"key":"B43","first-page":"1","article-title":"Age-adjusted death rates: trend data based on the year 2000 standard population","volume":"49","author":"Hoyert","year":"2001","journal-title":"Natl Vital Stat Rep."},{"key":"B44","unstructured":"Joinpoint Regression Program, Version 5.4.0. Statistical Research and Applications Branch, Surveillance Research Program\n          \n          2025"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.0006-341X.2004.00256.x","article-title":"Comparability of segmented line regression models","volume":"60","author":"Kim","year":"2004","journal-title":"Biometrics."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:118050","article-title":"Guidance for selecting model options in the national cancer institute joinpoint regression software","author":"Irimata","year":"2022","journal-title":"Vital Health Stat 2."},{"key":"B47","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.3390\/ijerph18168365","article-title":"Using autoregressive integrated moving average (ARIMA) modelling to forecast symptom complexity in an ambulatory oncology clinic: harnessing predictive analytics and patient-reported outcomes","volume":"18","author":"Watson","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B48","doi-asserted-by":"publisher","first-page":"908955","DOI":"10.3389\/fpubh.2022.908955","article-title":"The systematic analysis and 10-year prediction on disease burden of childhood cancer in China","volume":"10","author":"Zhu","year":"2022","journal-title":"Front Public Health."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e6880","DOI":"10.1002\/cam4.6880","article-title":"Prediction of early-onset colorectal cancer mortality rates in the United States using machine learning","volume":"13","author":"Ali","year":"2024","journal-title":"Cancer Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1160\/TH15-08-0686","article-title":"Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study","volume":"117","author":"Cohen","year":"2017","journal-title":"Thromb Haemost."},{"key":"B51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/bloodadvances.2021005590","article-title":"The incidence of cancer-associated thrombosis is increasing over time","volume":"6","author":"Mahajan","year":"2022","journal-title":"Blood Adv."},{"key":"B52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","article-title":"Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases","volume":"32","author":"van der Geest","year":"2015","journal-title":"Clin Exp Metastasis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3238\/arztebl.m2022.0368","article-title":"The rising incidence of early-onset colorectal cancer","volume":"120","author":"Tanaka","year":"2023","journal-title":"Dtsch Arztebl Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","article-title":"Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data","volume":"26","author":"Sung","year":"2025","journal-title":"Lancet Oncol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.drup.2023.100937","article-title":"Exosomal circular RNAs: a chief culprit in cancer chemotherapy resistance","volume":"67","author":"Guo","year":"2023","journal-title":"Drug Resist Updat."},{"key":"B56","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41467-023-36334-1","article-title":"Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy","volume":"14","author":"Linares","year":"2023","journal-title":"Nat Commun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/CMAR.S273544","article-title":"Managing 5FU cardiotoxicity in colorectal cancer treatment","volume":"14","author":"Anaka","year":"2022","journal-title":"Cancer Manag Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3747\/co.v17i1.437","article-title":"Capecitabine-induced cardiotoxicity: case report and review of the literature","volume":"17","author":"Ang","year":"2010","journal-title":"Curr Oncol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3390\/ph16101441","article-title":"Recent perspectives on cardiovascular toxicity associated with colorectal cancer drug therapy","volume":"16","author":"Kashyap","year":"2023","journal-title":"Pharmaceuticals."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"in Signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell."},{"key":"B61","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jcecho.2011.05.007","article-title":"Cardiotoxicity of novel molecular targeted therapies of cancer","volume":"21","author":"Di Bella","year":"2011","journal-title":"J Cardiovasc Echogr."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1093\/annonc\/mdt019","article-title":"Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study","volume":"24","author":"Tsai","year":"2013","journal-title":"Ann Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e5946","DOI":"10.1097\/MD.0000000000005946","article-title":"The cardiotoxicity of cetuximab as single therapy in Chinese chemotherapy-refractory metastatic colorectal cancer patients","volume":"96","author":"Tang","year":"2017","journal-title":"Medicine."},{"key":"B64","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/OTT.S149716","article-title":"Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC","volume":"11","author":"Tang","year":"2017","journal-title":"Onco Targets Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/cells9010198","article-title":"Targeting aberrant RAS\/RAF\/MEK\/ERK signaling for cancer therapy","volume":"9","author":"Degirmenci","year":"2020","journal-title":"Cells."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e12705","DOI":"10.1097\/MD.0000000000012705","article-title":"Risk of regorafenib-induced cardiovascular events in patients with solid tumors: a systematic review and meta-analysis","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jaccao.2022.04.007","article-title":"Late-onset immunotherapy-induced myocarditis 2 years after checkpoint inhibitor initiation","volume":"4","author":"Nguyen","year":"2022","journal-title":"JACC CardioOncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"103782","DOI":"10.1016\/j.critrevonc.2022.103782","article-title":"Venous thromboembolism in cancer and cancer immunotherapy","volume":"178","author":"Kacimi","year":"2022","journal-title":"Crit Rev Oncol Hematol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-publhealth-031912-114350","article-title":"Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors","volume":"34","author":"Schottenfeld","year":"2013","journal-title":"Annu Rev Public Health."},{"key":"B71","doi-asserted-by":"publisher","first-page":"162","DOI":"10.17179\/excli2021-4456","article-title":"Epidemiology and biology of early onset colorectal cancer","volume":"21","author":"Venugopal","year":"2022","journal-title":"EXCLI J."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/apt.16638","article-title":"Clinicopathological characteristics of early onset colorectal cancer","volume":"54","author":"Vuik","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1097\/JS9.0000000000001584","article-title":"Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled study","volume":"110","author":"Tang","year":"2024","journal-title":"Int J Surg."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6601a1","article-title":"Leading causes of death in nonmetropolitan and metropolitan areas-United States, 1999-2014","volume":"66","author":"Moy","year":"2017","journal-title":"MMWR Surveill Summ."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e2442451","DOI":"10.1001\/jamanetworkopen.2024.42451","article-title":"US cancer mortality trends among asian and pacific islander populations","volume":"7","author":"Zhu","year":"2024","journal-title":"JAMA Netw Open."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1850707\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:36:35Z","timestamp":1787636195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1850707\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":75,"alternative-id":["10.3389\/fpubh.2026.1850707"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1850707","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1850707"}}